Baxter IV Pump Set Clearlink™ Pump 1 Port 10 Drops / mL Drip Rate 0.2 Micron Filter 107 Inch Tubing Chemotherapy Medication - Case of 48 - 2R8858-CS

Baxter IV Pump Set Clearlink™ Pump 1 Port 10 Drops / mL Drip Rate 0.2 Micron Filter 107 Inch Tubing Chemotherapy Medication - Case of 48 - 2R8858-CS

Regular price $2,464.99
Sale price $2,464.99 Regular price
OFF Sold out
Shipping calculated at checkout.

50 In stock

Estimated deliver:

Flat-Rate Shipping from $8.25

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Reviews

Baxter IV Pump Set Clearlink™ Pump 1 Port 10 Drops / mL Drip Rate 0.2 Micron Filter 107 Inch Tubi...

Item Id 1185200
MF Id# 2R8858
Brand Clearlink™
Manufacturer Baxter
Country of Origin Costa Rica
Administration Method Pump
Application IV Pump Set
Back Check Valve Without Back Check Valve
Connection Type Male Luer Lock Connector
DEHP Indicator DEHP-Free Tubing
Drip Rate 10 Drops / mL Drip Rate
Filter 0.2 Micron Filter
Flow Control Type Roller Clamp / Slide Clamp
For Use With For use with SIGMA Spectrum and Spectrum IQ Infusion Pumps that have been calibrated for Baxter IV Set Tubing
Injection Port Type Grouping Needle-Free Port
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag N
Number of Ports 1 Port
On_Allocation N
Port Type Clearlink™ Luer Activated Port
Priming Volume 14 mL Priming Volume
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Spike Type Non-Vented Spike
Sterility Sterile Fluid Path
Supplier_ID 488167
Tubing Length 107 Inch Tubing
Tubing Length Range 97 to 120 Inches
Tubing Type Standard Bore Tubing
Type Chemotherapy Medication
UNSPSC Code 42221609

Features

  • All sets must include a Blue Slide Clamp on the section of the set to be placed into the Pump.
  • Fluid path does not contain DEHP; Outer layer of polyethylene lined tubing contains DEHP.
  • 0.2 Micron Filter

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
About your query!
Recently Viewed